Previous 10 | Next 10 |
The United States District Court for the Central District of California has ruled that a former Masimo (NASDAQ: MASI) engineer misappropriated trade secrets related to Masimo’s pulse oximetry technology. The former Masimo engineer, Marcelo Lamego, also served as Chief Tec...
Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 at 1:50 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of...
The following slide deck was published by Masimo Corporation in conjunction with their 2022 Q3 earnings call. For further details see: Masimo Corporation 2022 Q3 - Results - Earnings Call Presentation
Masimo Corporation (MASI) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Eli Kammerman – Vice President-Business Development and Investor Relations Joe Kiani – Chairman and Chief Executive Officer Micah Young ...
Masimo press release ( NASDAQ: MASI ): Q3 Non-GAAP EPS of $1.00 beats by $0.08 . Revenue of $549.3M (+78.7% Y/Y) beats by $15.86M . Healthcare revenue was $327 million, representing 6% reported growth and 10% constant currency growth; and Non-healthcare rev...
Third Quarter 2022 Highlights Consolidated revenue was $549 million; Healthcare revenue was $327 million, representing 6% reported growth and 10% constant currency growth; and Non-healthcare revenue was $222 million. Masimo (Nasdaq: MASI) today announced its ...
Stryker (NYSE: SYK) and Masimo (NASDAQ: MASI) aren't household names, but their lack of familiarity with the general public belies the steady revenue growth of these two medtech stocks. As the tech sector in general has fallen out of favor this year, both stocks are down. ...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release third quarter 2022 financial results for the period ended October 1, 2022, after the market closes on Tuesday, November 8, 2022. The conference call to review the resul...
Masimo Corp. ( NASDAQ: MASI ) filed a counterclaim against Politan Capital after the activist sued the medical monitoring company on Friday. "Politan is refusing to provide information about its significant financial backers and “sidecar vehicles” created f...
Update 1:15pm: Adds Masimo response to lawsuit. A Masimo Corp. ( NASDAQ: MASI ) activist investor has filed a lawsuit in Delaware after the medical monitoring company added some new bylaws that the activist alleges is trying to thwart its efforts. Politan Capital...
News, Short Squeeze, Breakout and More Instantly...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...